Prevalence of Potential Drug-Drug Interactions in Patients of the Swiss HIV Cohort Study in the Era of HIV Integrase Inhibitors.
Elisabeth DeutschmannHeiner C BucherSteffen JaeckelSara GibbonsKatie McAllisterAlexandra U ScherrerDominique L BraunMatthias CavassiniAnna HachfeldAlexandra CalmyManuel BattegayMichela CiprianiLuigia ElziJames YoungBeatriz Lopez-CentenoJuan BerenguerSaye KhooGiusi MoffaCatia Marzolininull nullPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
Prevalence of PDDIs was lower with more widespread use of INIs in 2018 than in 2008. Continued use of boosted regimens and increasing needs for co-medications in this aging population impeded lower rates of PDDIs.
Keyphrases
- antiretroviral therapy
- hiv positive
- hiv infected
- hiv testing
- human immunodeficiency virus
- hepatitis c virus
- risk factors
- end stage renal disease
- hiv aids
- ejection fraction
- newly diagnosed
- men who have sex with men
- prognostic factors
- emergency department
- south africa
- patient reported outcomes
- human health
- risk assessment
- climate change